Cargando…

Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus

PURPOSE: To evaluate the performance of serum procalcitonin (PCT) concentrations to diagnose fungal infection in patients with systemic lupus erythematosus (SLE). PATIENTS AND METHODS: From January 2017 to October 2020, SLE patients hospitalized for serious infection with an identified single bacter...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shuangjun, Ma, Jun, Fan, Chenyu, Tang, Chao, Chen, Yi, Xie, Cuiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605806/
https://www.ncbi.nlm.nih.gov/pubmed/34815675
http://dx.doi.org/10.2147/IDR.S337871
_version_ 1784602231499128832
author He, Shuangjun
Ma, Jun
Fan, Chenyu
Tang, Chao
Chen, Yi
Xie, Cuiying
author_facet He, Shuangjun
Ma, Jun
Fan, Chenyu
Tang, Chao
Chen, Yi
Xie, Cuiying
author_sort He, Shuangjun
collection PubMed
description PURPOSE: To evaluate the performance of serum procalcitonin (PCT) concentrations to diagnose fungal infection in patients with systemic lupus erythematosus (SLE). PATIENTS AND METHODS: From January 2017 to October 2020, SLE patients hospitalized for serious infection with an identified single bacterial or fungal pathogen, as well as PCT measured within 24h after admission were included. The diagnostic performance of PCT was evaluated independently and in combination with the white blood cell (WBC) count, C-reactive protein (CRP) level, and erythrocyte sedimentation rate (ESR). The analysis included the sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios, and the crude and adjusted area under the receiver operating characteristic curve (AUROC). RESULTS: Sixty-nine patients were included; 26 had a fungal infection (38%) and 43 had a bacterial infection (22 gram-positive and 21 gram-negative). Fungal infection patients were mainly distributed in the respiratory group (88.5%), and bacterial infection distribution were more prevalent in respiratory group (44.2%) and abdominal/urinary group (23.3%). The PCT concentration was significantly lower in fungal infections than bacterial infections (fungal: 0.22 ng/mL, interquartile range [IQR], 0.09–0.44 vs bacterial: 0.60 ng/mL, IQR, 0.16–5.74; p = 0.016) and differed significantly between different infection sites (p = 0.022). PCT had better diagnostic performance for predicting fungal infection (AUROC = 0.731) than the WBC count (AUROC = 0.581), the CRP level (AUROC = 0.716), and ESR (AUROC = 0.583). PCT and ESR together had the best diagnostic performance, with 46.2% sensitivity and 88.4% specificity. Further, the AUROC increased compared to PCT alone but was statistically insignificant (p = 0.693). CONCLUSION: For SLE patients with serious infection, the PCT concentration had better diagnostic accuracy for predicting fungal infection than the WBC count, the CRP level, and ESR. Combining PCT and ESR obtained the highest AUROC and provided an acceptable discrimination performance.
format Online
Article
Text
id pubmed-8605806
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86058062021-11-22 Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus He, Shuangjun Ma, Jun Fan, Chenyu Tang, Chao Chen, Yi Xie, Cuiying Infect Drug Resist Original Research PURPOSE: To evaluate the performance of serum procalcitonin (PCT) concentrations to diagnose fungal infection in patients with systemic lupus erythematosus (SLE). PATIENTS AND METHODS: From January 2017 to October 2020, SLE patients hospitalized for serious infection with an identified single bacterial or fungal pathogen, as well as PCT measured within 24h after admission were included. The diagnostic performance of PCT was evaluated independently and in combination with the white blood cell (WBC) count, C-reactive protein (CRP) level, and erythrocyte sedimentation rate (ESR). The analysis included the sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios, and the crude and adjusted area under the receiver operating characteristic curve (AUROC). RESULTS: Sixty-nine patients were included; 26 had a fungal infection (38%) and 43 had a bacterial infection (22 gram-positive and 21 gram-negative). Fungal infection patients were mainly distributed in the respiratory group (88.5%), and bacterial infection distribution were more prevalent in respiratory group (44.2%) and abdominal/urinary group (23.3%). The PCT concentration was significantly lower in fungal infections than bacterial infections (fungal: 0.22 ng/mL, interquartile range [IQR], 0.09–0.44 vs bacterial: 0.60 ng/mL, IQR, 0.16–5.74; p = 0.016) and differed significantly between different infection sites (p = 0.022). PCT had better diagnostic performance for predicting fungal infection (AUROC = 0.731) than the WBC count (AUROC = 0.581), the CRP level (AUROC = 0.716), and ESR (AUROC = 0.583). PCT and ESR together had the best diagnostic performance, with 46.2% sensitivity and 88.4% specificity. Further, the AUROC increased compared to PCT alone but was statistically insignificant (p = 0.693). CONCLUSION: For SLE patients with serious infection, the PCT concentration had better diagnostic accuracy for predicting fungal infection than the WBC count, the CRP level, and ESR. Combining PCT and ESR obtained the highest AUROC and provided an acceptable discrimination performance. Dove 2021-11-16 /pmc/articles/PMC8605806/ /pubmed/34815675 http://dx.doi.org/10.2147/IDR.S337871 Text en © 2021 He et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
He, Shuangjun
Ma, Jun
Fan, Chenyu
Tang, Chao
Chen, Yi
Xie, Cuiying
Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus
title Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus
title_full Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus
title_fullStr Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus
title_full_unstemmed Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus
title_short Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus
title_sort performance of procalcitonin to distinguish fungal from bacterial infections in patients with systemic lupus erythematosus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605806/
https://www.ncbi.nlm.nih.gov/pubmed/34815675
http://dx.doi.org/10.2147/IDR.S337871
work_keys_str_mv AT heshuangjun performanceofprocalcitonintodistinguishfungalfrombacterialinfectionsinpatientswithsystemiclupuserythematosus
AT majun performanceofprocalcitonintodistinguishfungalfrombacterialinfectionsinpatientswithsystemiclupuserythematosus
AT fanchenyu performanceofprocalcitonintodistinguishfungalfrombacterialinfectionsinpatientswithsystemiclupuserythematosus
AT tangchao performanceofprocalcitonintodistinguishfungalfrombacterialinfectionsinpatientswithsystemiclupuserythematosus
AT chenyi performanceofprocalcitonintodistinguishfungalfrombacterialinfectionsinpatientswithsystemiclupuserythematosus
AT xiecuiying performanceofprocalcitonintodistinguishfungalfrombacterialinfectionsinpatientswithsystemiclupuserythematosus